Melinta therapeutics to acquire tetraphase pharmaceuticals

Melinta therapeutics to acquire tetraphase pharmaceuticals.tetraphase pharmaceuticals inc - terminates merger agreement with acelrx to enter into merger agreement with melinta.tetraphase pharmaceuticals - agreement provides for $39.0 million upfront in cash plus potential contingent value rights cash payments of up to $16.0 million.tetraphase pharmaceuticals - board of tetraphase unanimously recommends stockholders tender shares in melinta tender offer once it is commenced.tetraphase pharmaceuticals inc - paid acelrx a termination fee in amount of $1.8 million.
ACRX Ratings Summary
ACRX Quant Ranking